Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Merck
Merck
AstraZeneca, Merck win quick OK for a rare disease drug — as the FDA declares it can still move fast during a crippling pandemic
Endpoints
Sat, 04/11/20 - 11:05 pm
AstraZenca
Merck
FDA
selumetinib
neurofibromatosis
Rexahn Pharmaceuticals Terminates Breast Cancer Study with Merck
BioSpace
Thu, 04/9/20 - 11:18 pm
Rexahn
triple negative breast cancer
Merck
Keytruda
FDA reviews Merck & Co’s Keytruda in new ‘tumour agnostic’ use
Pharmaforum
Wed, 04/8/20 - 10:55 am
Merck
Keytruda
tumor agnostic drugs
biomarkers
After putting aside a bitter legal feud, Alnylam and Dicerna chiefs make nice with an RNAi collaboration
Endpoints
Mon, 04/6/20 - 10:29 am
Alnylam
Dicerna
John Maraganore
Douglas Fambrough
RNAi
Merck
Seattle Genetics Issue Update on Padcev Label Expansion Study
Yahoo/Zacks.com
Sat, 04/4/20 - 11:21 pm
Seattle Genetics
Padcev
Merck
Keytruda
urothelial cancer
Merck scores new advance on tumor-agnostic front as Keytruda beat chemo-based regimens in a type of colorectal cancer
Endpoints
Thu, 04/2/20 - 11:59 pm
Merck
Keytruda
colorectal cancer
Pfizer, Merck, and Eli Lilly Will Pay Their Doctors to Get Back to Treating Patients During the COVID-19 Pandemic
Motley Fool
Thu, 04/2/20 - 11:54 pm
physicians
COVID-19
Pfizer
Merck
Eli Lilly
Merck and Bayer unveil the data behind their CV ‘success,’ underwhelming the industry
Endpoints
Mon, 03/30/20 - 10:32 am
Merck
Bayer
vericiguat
clinical trials
ACC: Bayer and Merck’s vericiguat leads off virtual meeting with positive phase 3 heart failure data
Fierce Biotech
Sat, 03/28/20 - 11:25 pm
ACC
Merck
Bayer
heart failure
vericiguat
clinical trials
Pharma giants including Novartis collaborate on COVID-19 therapies
Pharmaforum
Thu, 03/26/20 - 10:38 am
JNJ
Novartis
Boehringer Ingelheim
Biomerieux
Eisai
Eli Lilly
Gilead Sciences
GSK
Merck
Merck KGaA
Pfizer
Sanofi
R&D
COVID-19
diagnostics
vaccines
Merck hits goal in cough phase 3 but yet to quash tolerability concern
Fierce Biotech
Tue, 03/17/20 - 12:14 pm
Merck
gefapixant
chronic cough
clinical trials
Drug makers grounding salespeople as coronavirus impact on business spreads
Stat
Mon, 03/16/20 - 10:45 am
Amarin
Amgen
Merck
drug reps
coronaviruses
COVID-19
AstraZeneca and Merck's string of Lynparza successes ends in ovarian cancer
BioPharma Dive
Thu, 03/12/20 - 12:58 pm
AstraZeneca
Merck
cediranib
ovarian cancer
clinical trials
Lynparza
FDA Requires Boxed Warning for Singulair, Generics
RAPS.org
Wed, 03/4/20 - 08:01 pm
FDA
Merck
Singulair
asthma
Merck CEO Frazier finds fault in new studies suggesting pharma profits are too high
Fierce Pharma
Wed, 03/4/20 - 12:00 am
JAMA
profits
Merck
Ken Frazier
Pharma CEOs
Pharmacquired: Where are all the deals?
BioPharma Dive
Thu, 02/27/20 - 10:46 am
M&A
Gilead Sciences
Biogen
Sanofi
Eli Lilly
GSK
Merck
Vertex Pharmaceuticals
Is Merck a Better Buy After Announcing Spinoff?
Motley Fool
Mon, 02/24/20 - 10:43 am
Merck
spinoffs
Women's Health
biosimilars
Merck's Chief Digital Officer Leaves to Join Marriott
Motley Fool
Thu, 02/20/20 - 11:37 pm
Merck
chief digital officers
FDA Rejects Merck's 6-Week Dosing Schedule for Keytruda
BioSpace
Wed, 02/19/20 - 10:03 am
Merck
Keytruda
FDA
Merck's Ebola Vaccine Approved for Use in Four African Countries
Motley Fool
Sat, 02/15/20 - 02:24 pm
Merck
Africa
vaccines
Ervebo
ebola virus
Congo
Ghana
Zambia
Burundi
Pages
« first
‹ previous
…
39
40
41
42
43
44
45
46
47
…
next ›
last »